Multi-omics Mechanisms of Lifestyle Intervention in Regulating Blood Glucose

Plain-language summary

This study examines the multi-omics mechanisms by which lifestyle management helps regulate blood glucose. Individuals aged 18 to 70 who did not meet specific exclusion criteria could take part. This was a study without a clinical phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Shanghai 6th People's Hospital

Intervention

Lifestyle Management

Start date

8/31/2025

Estimated completion

10/30/2025

Countries

China

Related genes

Locations

• Shanghai, China

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Aged 18-70 years

Exclusion Criteria:

* Severe chronic diabetic complications or recent acute diabetic complications
* Type 1 diabetes mellitus
* Early-onset diabetes
* Patients currently using insulin therapy
* Recent severe hypoglycemic episodes
* Secondary obesity
* Pregnancy, severe hepatic/renal diseases, thyroid disorders, acute infections, psychiatric disorders, or other conditions that may interfere with study outcomes